{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T01:39:39Z","timestamp":1773193179535,"version":"3.50.1"},"reference-count":75,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes &amp; Metabolic Syndrome: Clinical Research &amp; Reviews"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.dsx.2019.01.036","type":"journal-article","created":{"date-parts":[[2019,1,27]],"date-time":"2019-01-27T05:20:48Z","timestamp":1548566448000},"page":"1123-1129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Potential role of Peroxisome Proliferator Activated Receptor gamma analogues in regulation of endothelial progenitor cells in diabetes mellitus: An overview"],"prefix":"10.1016","volume":"13","author":[{"given":"Manik","family":"Chhabra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saurabh","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Supplement 1","key":"10.1016\/j.dsx.2019.01.036_bib1","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.2337\/dc14-S081","article-title":"Diagnosis and classification of diabetes mellitus","volume":"37","author":"Association","year":"2014","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.dsx.2019.01.036_bib2","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2337\/diabetes.53.1.195","article-title":"Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes","volume":"53","author":"Loomans","year":"2004","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.dsx.2019.01.036_bib3","doi-asserted-by":"crossref","first-page":"282","DOI":"10.2174\/1874467211205020282","article-title":"Effects of PPAR\u03b3 ligands on vascular tone","volume":"5","author":"Salomone","year":"2012","journal-title":"Curr Mol Pharmacol"},{"issue":"10","key":"10.1016\/j.dsx.2019.01.036_bib4","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.2165\/00003495-200262100-00004","article-title":"Metabolic and additional vascular effects of thiazolidinediones","volume":"62","author":"Martens","year":"2002","journal-title":"Drugs"},{"issue":"12","key":"10.1016\/j.dsx.2019.01.036_bib5","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.2337\/dc10-1548","article-title":"Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement executive summary","volume":"33","author":"Colberg","year":"2010","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.dsx.2019.01.036_bib6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12933-017-0503-0","article-title":"Vildagliptin, but not glibenclamide, increases circulating endothelial progenitor cell number: a 12-month randomized controlled trial in patients with type 2 diabetes","volume":"16","author":"Dei Cas","year":"2017","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"10.1016\/j.dsx.2019.01.036_bib7","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.ecl.2006.06.001","article-title":"Peroxisome proliferator-activated receptor gamma agonists: their role as vasoprotective agents in diabetes","volume":"35","author":"Blaschke","year":"2006","journal-title":"Endocrinol Metabol Clin"},{"issue":"10","key":"10.1016\/j.dsx.2019.01.036_bib8","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.2337\/db07-0069","article-title":"The peroxisome proliferator\u2013activated receptor-\u03b3 agonist pioglitazone increases number and function of endothelial progenitor cells in patients with coronary artery disease and normal glucose tolerance","volume":"56","author":"Werner","year":"2007","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.dsx.2019.01.036_bib9","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/apha.12646","article-title":"Endothelial dysfunction and vascular disease\u2013a 30th anniversary update","volume":"219","author":"Vanhoutte","year":"2017","journal-title":"Acta Physiol"},{"issue":"7","key":"10.1016\/j.dsx.2019.01.036_bib10","doi-asserted-by":"crossref","first-page":"a006692","DOI":"10.1101\/cshperspect.a006692","article-title":"Human endothelial progenitor cells","volume":"2","author":"Yoder","year":"2012","journal-title":"Cold Spring Harbor Perspect Med"},{"issue":"3","key":"10.1016\/j.dsx.2019.01.036_bib11","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.tibtech.2016.09.007","article-title":"Human endothelial cell models in biomaterial research","volume":"35","author":"Hauser","year":"2017","journal-title":"Trends Biotechnol"},{"issue":"3","key":"10.1016\/j.dsx.2019.01.036_bib12","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.dsx.2016.08.007","article-title":"Endothelial progenitor cells dysfunction and impaired tissue reparation: the missed link in diabetes mellitus development","volume":"11","author":"Berezin","year":"2017","journal-title":"Diabetes Metab Syndrome: Clin Res Rev"},{"issue":"1","key":"10.1016\/j.dsx.2019.01.036_bib13","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11154-010-9134-4","article-title":"Endothelial dysfunction in diabetes mellitus: molecular mechanisms and clinical implications","volume":"11","author":"Tabit","year":"2010","journal-title":"Rev Endocr Metab Disord"},{"issue":"9165","key":"10.1016\/j.dsx.2019.01.036_bib14","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/S0140-6736(99)01046-6","article-title":"Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study","volume":"353","author":"Schmidt","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.dsx.2019.01.036_bib15","series-title":"XXXVIII congress of the Spanish society of physiological sciences (SECF)","article-title":"Role of endothelium-derived hyperpolarization in the vasodilatation of rat intrarenal arteries","author":"Pinilla","year":"2016"},{"issue":"1","key":"10.1016\/j.dsx.2019.01.036_bib16","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.atherosclerosis.2006.06.026","article-title":"The PPAR-\u03b3 agonist pioglitazone increases neoangiogenesis and prevents apoptosis of endothelial progenitor cells","volume":"192","author":"Gensch","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.dsx.2019.01.036_bib17","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.2337\/db07-0765","article-title":"Selective activation of peroxisome induces neoangiogenesis through a vascular endothelial growth factor\u2013dependent mechanism","volume":"57","author":"Biscetti","year":"2008","journal-title":"Diabetes"},{"issue":"15","key":"10.1016\/j.dsx.2019.01.036_bib18","doi-asserted-by":"crossref","first-page":"9960","DOI":"10.1073\/pnas.132254199","article-title":"Predominant selection of T cells specific for the glycosylated collagen type II epitope (263\u2013270) in humanized transgenic mice and in rheumatoid arthritis","volume":"99","author":"B\u00e4cklund","year":"2002","journal-title":"Proc Natl Acad Sci Unit States Am"},{"issue":"5","key":"10.1016\/j.dsx.2019.01.036_bib19","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1365-2559.1988.tb01967.x","article-title":"A\u00a0simple guide to the terminology and application of leucocyte monoclonal antibodies","volume":"12","author":"Chan","year":"1988","journal-title":"Histopathology"},{"issue":"1","key":"10.1016\/j.dsx.2019.01.036_bib20","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/1097-0142(19850701)56:1<95::AID-CNCR2820560116>3.0.CO;2-K","article-title":"Monoclonal antibodies reactive with B-lymphocytes and histiocytes in paraffin sections","volume":"56","author":"Okon","year":"1985","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.dsx.2019.01.036_bib21","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s10565-007-0177-6","article-title":"Endothelial progenitor cells: characterization, in\u00a0vitro expansion, and prospects for autologous cell therapy","volume":"23","author":"Smadja","year":"2007","journal-title":"Cell Biol Toxicol"},{"issue":"4","key":"10.1016\/j.dsx.2019.01.036_bib22","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1161\/01.RES.0000137877.89448.78","article-title":"Endothelial progenitor cells: characterization and role in vascular biology","volume":"95","author":"Urbich","year":"2004","journal-title":"Circ Res"},{"issue":"22","key":"10.1016\/j.dsx.2019.01.036_bib23","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1161\/CIRCULATIONAHA.104.504340","article-title":"Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair","volume":"111","author":"Schmidt-Lucke","year":"2005","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.dsx.2019.01.036_bib24","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1161\/01.RES.85.3.221","article-title":"Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization","volume":"85","author":"Asahara","year":"1999","journal-title":"Circ Res"},{"issue":"5302","key":"10.1016\/j.dsx.2019.01.036_bib25","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1126\/science.275.5302.964","article-title":"Isolation of putative progenitor endothelial cells for angiogenesis","volume":"275","author":"Asahara","year":"1997","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.dsx.2019.01.036_bib26","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1161\/ATVBAHA.107.155960","article-title":"Assessing identity, phenotype, and fate of endothelial progenitor cells","volume":"28","author":"Hirschi","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.dsx.2019.01.036_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/9780470151808.sc02c01s6","article-title":"Isolation and characterization of endothelial progenitor cells from human blood","volume":"6","author":"Mead","year":"2008","journal-title":"Curr Protoc Stem Cell Biol"},{"issue":"9","key":"10.1016\/j.dsx.2019.01.036_bib28","first-page":"1243","article-title":"Endothelial progenitor cells: sowing the seeds for vascular repair","volume":"100","author":"Lamping","year":"2007","journal-title":"Am Heart Assoc"},{"issue":"9","key":"10.1016\/j.dsx.2019.01.036_bib29","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1161\/01.STR.0000236064.19293.79","article-title":"Peripheral blood CD34+ KDR+ endothelial progenitor cells are determinants of subclinical atherosclerosis in a middle-aged general population","volume":"37","author":"Fadini","year":"2006","journal-title":"Stroke"},{"issue":"4","key":"10.1016\/j.dsx.2019.01.036_bib30","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1152\/japplphysiol.01210.2007","article-title":"A\u00a0maximal exercise bout increases the number of circulating CD34+\/KDR+ endothelial progenitor cells in healthy subjects. Relation with lipid profile","volume":"104","author":"Van Craenenbroeck","year":"2008","journal-title":"J\u00a0Appl Physiol"},{"issue":"3","key":"10.1016\/j.dsx.2019.01.036_bib31","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.mvr.2010.05.008","article-title":"Mobilization, endothelial differentiation and functional capacity of endothelial progenitor cells after ischemic stroke","volume":"80","author":"Navarro-Sobrino","year":"2010","journal-title":"Microvasc Res"},{"issue":"1","key":"10.1016\/j.dsx.2019.01.036_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2008.09.029","article-title":"Mobilization of bone marrow-derived Oct-4+ SSEA-4+ very small embryonic-like stem cells in patients with acute myocardial infarction","volume":"53","author":"Wojakowski","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.dsx.2019.01.036_bib33","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1182\/blood-2006-08-043471","article-title":"Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem\/progenitor cell principals","volume":"109","author":"Yoder","year":"2007","journal-title":"Blood"},{"issue":"22","key":"10.1016\/j.dsx.2019.01.036_bib34","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1161\/01.CIR.0000039526.42991.93","article-title":"Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures","volume":"106","author":"Tepper","year":"2002","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.dsx.2019.01.036_bib35","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1161\/CIRCULATIONAHA.106.684381","article-title":"Oxidant stress impairs in\u00a0vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus: restoration by the peroxisome proliferator-activated receptor-\u03b3 agonist rosiglitazone","volume":"116","author":"Sorrentino","year":"2007","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.dsx.2019.01.036_bib36","first-page":"434","article-title":"Macro-and microvascular endothelial dysfunction in diabetes: \u7cd6\u5c3f\u75c5\u8bf1\u5bfc\u7684\u5185\u76ae\u7ec6\u80de\u529f\u80fd\u635f\u4f24","volume":"9","author":"Shi","year":"2017","journal-title":"J\u00a0Diabetes"},{"issue":"6","key":"10.1016\/j.dsx.2019.01.036_bib37","first-page":"853","article-title":"Endothelial dysfunction in diabetes mellitus","volume":"3","author":"Hadi","year":"2007","journal-title":"Vasc Health Risk Manag"},{"issue":"2","key":"10.1016\/j.dsx.2019.01.036_bib38","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.diabet.2016.07.034","article-title":"Impaired development and dysfunction of endothelial progenitor cells in type 2 diabetic mice","volume":"43","author":"Tsukada","year":"2017","journal-title":"Diabetes Metab"},{"issue":"5","key":"10.1016\/j.dsx.2019.01.036_bib39","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1161\/CIRCULATIONAHA.108.789297","article-title":"Dual angiogenic and neurotrophic effects of bone marrow\u2013derived endothelial progenitor cells on diabetic neuropathy","volume":"119","author":"Jeong","year":"2009","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.dsx.2019.01.036_bib40","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.2337\/db07-1520","article-title":"Hyperglycemia-induced reactive oxygen species toxicity to endothelial cells is dependent on paracrine mediators","volume":"57","author":"Busik","year":"2008","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.dsx.2019.01.036_bib41","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2337\/diabetes.47.4.507","article-title":"PPAR-gamma: adipogenic regulator and thiazolidinedione receptor","volume":"47","author":"Spiegelman","year":"1998","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.dsx.2019.01.036_bib42","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.cmet.2007.03.010","article-title":"The small molecule harmine is an antidiabetic cell-type-specific regulator of PPAR\u03b3 expression","volume":"5","author":"Waki","year":"2007","journal-title":"Cell Metabol"},{"key":"10.1016\/j.dsx.2019.01.036_bib43","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.2741\/2802","article-title":"Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists","volume":"13","author":"Kapadia","year":"2008","journal-title":"Front Biosci: J Virt Libr"},{"key":"10.1016\/j.dsx.2019.01.036_bib44","series-title":"Endothelial progenitor cells of diabetic patients with acute coronary syndromes: effects of antidiabetic and lipid lowering drugs","author":"Ant\u00f3nio","year":"2015"},{"issue":"6A","key":"10.1016\/j.dsx.2019.01.036_bib45","first-page":"3593","article-title":"Pioglitazone, a ligand for peroxisome proliferator-activated receptor-\u03b3 acts as an inhibitor of colon cancer liver metastasis","volume":"28","author":"Takano","year":"2008","journal-title":"Anticancer Res"},{"issue":"6785","key":"10.1016\/j.dsx.2019.01.036_bib46","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/35013000","article-title":"Roles of PPARs in health and disease","volume":"405","author":"Kersten","year":"2000","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.dsx.2019.01.036_bib47","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0165-6147(00)01559-5","article-title":"PPAR-\u03b3 agonists: therapeutic role in diabetes, inflammation and cancer","volume":"21","author":"Murphy","year":"2000","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"10.1016\/j.dsx.2019.01.036_bib48","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.biochi.2004.10.021","article-title":"PPAR\u03b3, 10 years later","volume":"87","author":"Lazar","year":"2005","journal-title":"Biochimie"},{"issue":"22","key":"10.1016\/j.dsx.2019.01.036_bib49","doi-asserted-by":"crossref","first-page":"12953","DOI":"10.1074\/jbc.270.22.12953","article-title":"An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor \u03b3 (PPAR\u03b3)","volume":"270","author":"Lehmann","year":"1995","journal-title":"J\u00a0Biol Chem"},{"issue":"2","key":"10.1016\/j.dsx.2019.01.036_bib50","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.neuint.2006.03.020","article-title":"PPAR\u03b3 as a therapeutic target in central nervous system diseases","volume":"49","author":"Sundararajan","year":"2006","journal-title":"Neurochem Int"},{"issue":"10","key":"10.1016\/j.dsx.2019.01.036_bib51","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1001\/jama.298.10.1180","article-title":"Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials","volume":"298","author":"Lincoff","year":"2007","journal-title":"Jama"},{"issue":"9593","key":"10.1016\/j.dsx.2019.01.036_bib52","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0140-6736(07)61514-1","article-title":"Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials","volume":"370","author":"Lago","year":"2007","journal-title":"Lancet"},{"issue":"13","key":"10.1016\/j.dsx.2019.01.036_bib53","doi-asserted-by":"crossref","first-page":"7614","DOI":"10.1073\/pnas.95.13.7614","article-title":"Expression of the peroxisome proliferator-activated receptor \u03b3 (PPAR\u03b3) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein","volume":"95","author":"Ricote","year":"1998","journal-title":"Proc Natl Acad Sci Unit States Am"},{"issue":"3","key":"10.1016\/j.dsx.2019.01.036_bib54","doi-asserted-by":"crossref","first-page":"H1037","DOI":"10.1152\/ajpheart.00677.2004","article-title":"Peroxisome proliferator-activated receptors and cardiovascular remodeling","volume":"288","author":"Schiffrin","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"4","key":"10.1016\/j.dsx.2019.01.036_bib55","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.amjcard.2006.11.010","article-title":"Effects of peroxisome proliferator-activated receptors on lipoprotein metabolism and glucose control in type 2 diabetes mellitus","volume":"99","author":"Rosenson","year":"2007","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.dsx.2019.01.036_bib56","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.atherosclerosis.2005.03.039","article-title":"PPAR\u03b3-agonist rosiglitazone increases number and migratory activity of cultured endothelial progenitor cells","volume":"183","author":"Pistrosch","year":"2005","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.dsx.2019.01.036_bib57","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/hh1301.093953","article-title":"Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease","volume":"89","author":"Vasa","year":"2001","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.dsx.2019.01.036_bib58","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1530\/eje.1.01948","article-title":"Effect of rosiglitazone on insulin resistance, C-reactive protein and endothelial function in non-obese young women with polycystic ovary syndrome","volume":"153","author":"Tarkun","year":"2005","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.dsx.2019.01.036_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2006.07.029","article-title":"Pioglitazone increases the numbers and improves the functional capacity of endothelial progenitor cells in patients with diabetes mellitus","volume":"152","author":"Wang","year":"2006","journal-title":"Am Heart J"},{"issue":"5","key":"10.1016\/j.dsx.2019.01.036_bib60","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1463-1326.2011.01367.x","article-title":"Effects of pioglitazone versus metformin on circulating endothelial microparticles and progenitor cells in patients with newly diagnosed type 2 diabetes\u2014a randomized controlled trial","volume":"13","author":"Esposito","year":"2011","journal-title":"Diabetes Obes Metab"},{"issue":"8","key":"10.1016\/j.dsx.2019.01.036_bib61","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1111\/j.1476-5381.2009.00450.x","article-title":"Rosiglitazone via upregulation of Akt\/eNOS pathways attenuates dysfunction of endothelial progenitor cells, induced by advanced glycation end products","volume":"158","author":"Liang","year":"2009","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/j.dsx.2019.01.036_bib62","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.atherosclerosis.2011.02.011","article-title":"Pioglitazone activates aortic telomerase and prevents stress-induced endothelial apoptosis","volume":"216","author":"Werner","year":"2011","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.dsx.2019.01.036_bib63","first-page":"321","article-title":"Activation of peroxisome proliferator-activated receptor \u03b3 improves endothelial dysfunction induced by Porphyromonas gingivalis through the PI3K\/Akt, ERK and NF\u03baB pathways","volume":"10","author":"Li","year":"2017","journal-title":"Int J Clin Exp Pathol"},{"issue":"11","key":"10.1016\/j.dsx.2019.01.036_bib64","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/nm948","article-title":"Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells","volume":"9","author":"Aicher","year":"2003","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.dsx.2019.01.036_bib65","doi-asserted-by":"crossref","first-page":"H822","DOI":"10.1152\/ajpheart.1986.250.5.H822","article-title":"Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor","volume":"250","author":"Rubanyi","year":"1986","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"10.1016\/j.dsx.2019.01.036_bib66","doi-asserted-by":"crossref","first-page":"G112","DOI":"10.1152\/ajpgi.00442.2006","article-title":"Pioglitazone reverses insulin resistance and impaired CCK-stimulated pancreatic secretion in eNOS (\u2212\/\u2212) mice: therapy for exocrine pancreatic disorders?","volume":"293","author":"Reddy","year":"2007","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"6","key":"10.1016\/j.dsx.2019.01.036_bib67","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1253\/circj.72.998","article-title":"Effect of pioglitazone on nitroglycerin-induced impairment of nitric oxide bioavailability by a catheter-type nitric oxide sensor","volume":"72","author":"Ikejima","year":"2008","journal-title":"Circ J"},{"key":"10.1016\/j.dsx.2019.01.036_bib68","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/354517","article-title":"Human miR-221\/222 in physiological and atherosclerotic vascular remodeling","volume":"2015","author":"Chistiakov","year":"2015","journal-title":"BioMed Res Int"},{"issue":"4","key":"10.1016\/j.dsx.2019.01.036_bib69","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1161\/CIRCRESAHA.108.185363","article-title":"A\u00a0necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia","volume":"104","author":"Liu","year":"2009","journal-title":"Circ Res"},{"issue":"9","key":"10.1016\/j.dsx.2019.01.036_bib70","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.2337\/diacare.26.9.2493","article-title":"Antiatherogenic effect of pioglitazone in type 2 diabetic patients irrespective of the responsiveness to its antidiabetic effect","volume":"26","author":"Satoh","year":"2003","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.dsx.2019.01.036_bib71","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1161\/HYPERTENSIONAHA.111.179820","article-title":"Age-related decline in reendothelialization capacity of human endothelial progenitor cells is restored by shear stress","volume":"59","author":"Xia","year":"2012","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.dsx.2019.01.036_bib72","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.atherosclerosis.2008.05.034","article-title":"Role of inflammation and oxidative stress in endothelial progenitor cell function and mobilization: therapeutic implications for cardiovascular diseases","volume":"201","author":"Tousoulis","year":"2008","journal-title":"Atherosclerosis"},{"issue":"9","key":"10.1016\/j.dsx.2019.01.036_bib73","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1111\/j.1600-6143.2006.01433.x","article-title":"mTOR inhibition induces endothelial progenitor cell death","volume":"6","author":"Miriuka","year":"2006","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.dsx.2019.01.036_bib74","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.yexcr.2004.07.002","article-title":"Rapamycin inhibits proliferation and differentiation of human endothelial progenitor cells in\u00a0vitro","volume":"300","author":"Butzal","year":"2004","journal-title":"Exp Cell Res"},{"issue":"1","key":"10.1016\/j.dsx.2019.01.036_bib75","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015909","article-title":"PPAR-\u03b3 ligands repress TGF\u03b2-induced myofibroblast differentiation by targeting the PI3K\/Akt pathway: implications for therapy of fibrosis","volume":"6","author":"Kulkarni","year":"2011","journal-title":"PLoS One"}],"container-title":["Diabetes &amp; Metabolic Syndrome: Clinical Research &amp; Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402118306398?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402118306398?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T09:09:14Z","timestamp":1761728954000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402118306398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":75,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S1871402118306398"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2019.01.036","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential role of Peroxisome Proliferator Activated Receptor gamma analogues in regulation of endothelial progenitor cells in diabetes mellitus: An overview","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2019.01.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Diabetes India. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}